The genetic landscape of type 2 diabetes in mice

SM Clee, AD Attie - Endocrine reviews, 2007 - academic.oup.com
Inbred mouse strains provide genetic diversity comparable to that of the human population.
Like humans, mice have a wide range of diabetes-related phenotypes. The inbred mouse …

Mouse models for the study of autoimmune type 1 diabetes: a NOD to similarities and differences to human disease

JP Driver, DV Serreze, YG Chen - Seminars in immunopathology, 2011 - Springer
For almost 30 years, the non-obese diabetic (NOD) mouse has served as the primary model
for dissecting the genetic and pathogenic basis for T-lymphocyte-mediated autoimmune type …

In mice with type 2 diabetes, a vascular endothelial growth factor (VEGF)-activating transcription factor modulates VEGF signaling and induces therapeutic …

Y Li, S Hazarika, D Xie, AM Pippen, CD Kontos… - Diabetes, 2007 - Am Diabetes Assoc
Peripheral arterial disease is a major complication of diabetes. The ability to promote
therapeutic angiogenesis may be limited in diabetes. Type 2 diabetes was induced by high …

Establishment of “The Gene Mine”: a resource for rapid identification of complex trait genes

G Morahan, L Balmer, D Monley - Mammalian Genome, 2008 - Springer
Identification of genes underlying complex traits presents a challenge to which geneticists
have responded with many diverse approaches. A common feature of these approaches is …

Genetic evidence that the differential expression of the ligand-independent isoform of CTLA-4 is the molecular basis of the Idd5. 1 type 1 diabetes region in nonobese …

M Araki, D Chung, S Liu, DB Rainbow… - The Journal of …, 2009 - journals.aai.org
Abstract Idd5. 1 regulates T1D susceptibility in nonobese diabetic (NOD) mice and has two
notable candidate genes, Ctla4 and Icos. Reduced expression of one of the four CTLA-4 …

Aberrant lipid accumulation in the mouse visceral yolk sac resulting from maternal diabetes and obesity

M Zhang, JM Salbaum, S Jones, D Burk… - Frontiers in Cell and …, 2023 - frontiersin.org
Maternal diabetes and obesity in pregnancy are well-known risk factors for structural birth
defects, including neural tube defects and congenital heart defects. Progeny from affected …

CD4+ Foxp3+ regulatory T cells in the control of autoimmunity: in vivo veritas

CA Piccirillo, E d'Hennezel, E Sgouroudis… - Current opinion in …, 2008 - Elsevier
The immune system requires a homeostatic equilibrium between the mechanisms that
assure self-tolerance, those that control the capacity to mount life-long immunity to …

Dietary proteins as environmental modifiers of type 1 diabetes mellitus

DE Lefebvre, KL Powell, A Strom, FW Scott - Annu. Rev. Nutr., 2006 - annualreviews.org
▪ Abstract Type 1 diabetes is an autoimmune disease in which the patient's immune system
destroys the insulin-secreting β-cells in the pancreatic islets of Langerhans. A majority of …

Development of standardized insulin treatment protocols for spontaneous rodent models of type 1 diabetes

CW Grant, SK Duclos, CM Moran-Paul… - Comparative …, 2012 - ingentaconnect.com
Standardized protocols for maintaining near-normal glycemic levels in diabetic rodent
models for testing therapeutic agents to treat disease are unavailable. We developed …

Glucagon-like peptide-2 reduces intestinal permeability but does not modify the onset of type 1 diabetes in the nonobese diabetic mouse

I Hadjiyanni, KK Li, DJ Drucker - Endocrinology, 2009 - academic.oup.com
The development of type 1 diabetes (T1D) has been linked to environmental factors and
dietary components. Increasing evidence indicates that the integrity of the gut mucosa plays …